DOWNLOAD THIS WHITE PAPER
Virus-like particles: A practical alternative to cultured rubella virus.
The whitepaper will cover:
- The background and evolution of virology;
- The production and mechanisms of VLPs;
- The Native Antigen Company’s VLP portfolio;
- Potential applications of VLPs in research and development; and
- The specific application of VLPs for the diagnosis and management of rubella.
